Use of prenatal glucocorticoid therapy to prevent respiratory distress syndrome. A supporting view.
D000653:Amniotic Fluid / Q000378:metabolism; D001623:Betamethasone / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use; D005260:Female; D005312:Fetal Blood / Q000032:analysis; D005333:Fetus / Q000187:drug effects; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D006854:Hydrocortisone / Q000097:blood / Q000627:therapeutic use; D007231:Infant, Newborn; D007234:Infant, Premature; D010713:Phosphatidylcholines / Q000378:metabolism; D010919:Placebos; D011247:Pregnancy; D012127:Respiratory Distress Syndrome, Newborn / Q000517:prevention & control*; D013109:Sphingomyelins / Q000378:metabolism
D005938:Glucocorticoids; D010713:Phosphatidylcholines; D010919:Placebos; D013109:Sphingomyelins; D001623:Betamethasone; D006854:Hydrocortisone